Literature DB >> 33392049

Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?

Mostafa Vaghari-Tabari1,2, Soheila Moein3,4, Durdi Qujeq5,6, Mehrdad Kashifard7, Haydeh Alaoddolehei8, Karimollah Hajian-Tilaki9.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder.
OBJECTIVE: This study aimed to evaluate red blood cell distribution width (RDW) and mean platelet volume (MPV) as laboratory markers to discriminate IBS patients from both healthy controls and patients with inflammatory bowel disease (IBD).
METHODS: This case-control study enrolled patients referred to Ayatollah Rouhani Hospital, Endoscopy Department, Babol, Iran, for colonoscopy examination from 2015 to 2017. Fifty IBS patients were selected from among patients who had undergone a normal colonoscopy and showed symptoms matching the Rome III criteria. Fifty healthy participants and 50 IBD patients, matched for sex and age, were also enrolled in this study. Both RDW and MPV were measured and analysed by independent sample t-test and receiver operating characteristic curve analysis. A p-value of less than 0.05 was considered statistically significant.
RESULTS: While RDW was higher and MPV was lower among IBS patients compared to healthy controls (p = 0.047 and p = 0.001), there were no significant differences in RDW or MPV levels between IBS and IBD patients. The area under the curve of RDW in the discrimination between IBS and IBD was 0.620 (p = 0.039), and the area under the curve of MPV in the discrimination between healthy controls and IBS patients was 0.801 (p = 0.001).
CONCLUSION: Mean platelet volume is potentially a useful laboratory marker for distinguishing between IBS patients and healthy individuals. Red blood cell distribution width should be considered as a potential marker to distinguish among IBS and IBD patients.
© 2020. The Authors.

Entities:  

Keywords:  IBS; inflammatory bowel disease; irritable bowel syndrome; mean platelet volume; red blood cell distribution width

Year:  2020        PMID: 33392049      PMCID: PMC7756523          DOI: 10.4102/ajlm.v9i1.1001

Source DB:  PubMed          Journal:  Afr J Lab Med        ISSN: 2225-2002


  20 in total

1.  Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer.

Authors:  A J Bancroft; E W Abel; M Mclaren; J J Belch
Journal:  Platelets       Date:  2000-11       Impact factor: 3.862

2.  All Roads Lead to Rome: Update on Rome III Criteria and New Treatment Options.

Authors:  David Q Shih; Lola Y Kwan
Journal:  Gastroenterol Rep       Date:  2007       Impact factor: 3.651

3.  Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia.

Authors:  Chaima Abdelhafidh Sahli; Amina Bibi; Faida Ouali; Sondess Hadj Fredj; Boutheina Dakhlaoui; Rym Othmani; Naouel Laouini; Latifa Jouini; Fekria Ouenniche; Hajer Siala; Imed Touhami; Mariem Becher; Slaheddine Fattoum; Nour El Houda Toumi; Taieb Messaoud
Journal:  Clin Chem Lab Med       Date:  2013-11       Impact factor: 3.694

4.  Red blood cell distribution width (RDW) and human pathology. One size fits all.

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2014-09       Impact factor: 3.694

Review 5.  MiRNAs and inflammatory bowel disease: An interesting new story.

Authors:  Soheila Moein; Mostafa Vaghari-Tabari; Durdi Qujeq; Maryam Majidinia; Seyed Mohammad Nabavi; Bahman Yousefi
Journal:  J Cell Physiol       Date:  2018-11-11       Impact factor: 6.384

Review 6.  Lessons learned--resolving the enigma of genetic factors in IBS.

Authors:  Maria Gazouli; Mira M Wouters; Lejla Kapur-Pojskić; May-Bente Bengtson; Eitan Friedman; Gordana Nikčević; Christiana A Demetriou; Agata Mulak; Javier Santos; Beate Niesler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-04       Impact factor: 46.802

Review 7.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

8.  Positive Correlation of Fecal Calprotectin With Serum Antioxidant Enzymes in Patients With Inflammatory Bowel Disease: Accidental Numerical Correlation or a New Finding?

Authors:  Mostafa Vaghari-Tabari; Soheila Moein; Durdi Qujeq; Mehrdad Kashifard; Karimollah Hajian-Tilaki
Journal:  Am J Med Sci       Date:  2017-12-27       Impact factor: 2.378

Review 9.  Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.

Authors:  Lekha Saha
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

10.  Red cell distribution width: a novel marker of activity in inflammatory bowel disease.

Authors:  Atakan Yeşil; Ebubekir Senateş; Ibrahim Vedat Bayoğlu; Emrullah Düzgün Erdem; Refik Demirtunç; Ayşe Oya Kurdaş Övünç
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

View more
  3 in total

1.  Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China.

Authors:  Chengjiao Yao; Yilin Li; Lihong Luo; Fengjiao Xie; Qin Xiong; Tinglin Li; Chunrong Yang; Pei-Min Feng
Journal:  Dig Dis Sci       Date:  2022-05-03       Impact factor: 3.199

Review 2.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

3.  Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid.

Authors:  Hongfei Tu; Miao Li; Zhiyuan Chen; Jiamin Zhao; Huali Wang; Jingjing Qian; Cheng Wei; Yang Yang; Yue Zhu; Lingyun Zuo
Journal:  J Clin Lab Anal       Date:  2022-01-16       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.